Janux Therapeutics (JANX) News Today → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free JANX Stock Alerts $47.91 -2.08 (-4.16%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 3:38 AM | americanbankingnews.comHC Wainwright Boosts Janux Therapeutics (NASDAQ:JANX) Price Target to $63.00May 14 at 7:52 PM | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Trading Down 3.1%Janux Therapeutics (NASDAQ:JANX) Shares Down 3.1%May 13 at 3:46 PM | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Valneva (VALN), Janux Therapeutics Inc (JANX) and Kymera Therapeutics (KYMR)May 13 at 10:45 AM | markets.businessinsider.comAnalyst Ratings For Janux TherapeuticsMay 13 at 8:20 AM | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Price Target Raised to $63.00 at HC WainwrightHC Wainwright raised their price target on Janux Therapeutics from $50.00 to $63.00 and gave the stock a "buy" rating in a research note on Monday.May 13 at 5:09 AM | americanbankingnews.comCantor Fitzgerald Reiterates "Overweight" Rating for Janux Therapeutics (NASDAQ:JANX)May 13 at 2:16 AM | americanbankingnews.comQ2 2024 EPS Estimates for Janux Therapeutics, Inc. Raised by Wedbush (NASDAQ:JANX)May 13 at 1:34 AM | americanbankingnews.comReviewing Lucy Scientific Discovery (NASDAQ:LSDI) and Janux Therapeutics (NASDAQ:JANX)May 11, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for Janux Therapeutics, Inc. Cut by Analyst (NASDAQ:JANX)May 10, 2024 | marketbeat.comQ2 2024 EPS Estimates for Janux Therapeutics, Inc. Cut by William Blair (NASDAQ:JANX)Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) - Stock analysts at William Blair reduced their Q2 2024 earnings estimates for shares of Janux Therapeutics in a research note issued on Tuesday, May 7th. William Blair analyst M. Phipps now expects that the company will earn ($0.21) per shareMay 10, 2024 | americanbankingnews.comJanux Therapeutics (NASDAQ:JANX) PT Raised to $74.00 at WedbushMay 10, 2024 | americanbankingnews.comJanux Therapeutics, Inc. (NASDAQ:JANX) Given Average Recommendation of "Buy" by AnalystsMay 9, 2024 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Given "Overweight" Rating at Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and issued a $100.00 price objective on shares of Janux Therapeutics in a research note on Thursday.May 8, 2024 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Shares Down 11.5% Janux Therapeutics (NASDAQ:JANX) Stock Price Down 11.5%May 8, 2024 | benzinga.comJanux Therapeutics Options Trading: A Deep Dive into Market SentimentMay 8, 2024 | finance.yahoo.comJanux Therapeutics Reports Narrower Q1 Loss, Misses Revenue EstimatesMay 7, 2024 | businesswire.comJanux Therapeutics Reports First Quarter 2024 Financial Results and Business HighlightsMay 6, 2024 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Shares Gap Down to $64.78Janux Therapeutics (NASDAQ:JANX) Shares Gap Down to $64.78May 2, 2024 | msn.comJanux Therapeutics gains amid renewed takeover speculationMay 2, 2024 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Sets New 12-Month High at $64.79Janux Therapeutics (NASDAQ:JANX) Hits New 12-Month High at $64.79April 30, 2024 | finance.yahoo.comHere's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price StrengthApril 29, 2024 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Shares Up 11.7%Janux Therapeutics (NASDAQ:JANX) Trading 11.7% HigherApril 28, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Acquires 25,105 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Allspring Global Investments Holdings LLC boosted its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 2,166.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 26,264 shares of the company'sApril 24, 2024 | marketbeat.comCerity Partners LLC Makes New $654,000 Investment in Janux Therapeutics, Inc. (NASDAQ:JANX)Cerity Partners LLC purchased a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 60,933 shares of the company's stock, valued at approximaApril 17, 2024 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Shares Down 4.1% Janux Therapeutics (NASDAQ:JANX) Stock Price Down 4.1%April 17, 2024 | investorplace.comTake the Money and Run: 3 Overbought Stocks to Sell ASAPApril 17, 2024 | nasdaq.comValidea Detailed Fundamental Analysis - JANXApril 16, 2024 | msn.comJonesTrading Initiates Coverage of Janux Therapeutics (JANX) with Buy RecommendationApril 16, 2024 | msn.comJanux a new buy at Jones on lead assets for solid tumorsApril 16, 2024 | investorplace.comThese 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?April 16, 2024 | benzinga.comA Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 AnalystsApril 15, 2024 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Shares Gap Down to $52.65Janux Therapeutics (NASDAQ:JANX) Shares Gap Down to $52.65April 12, 2024 | fool.comWhy Janux Therapeutics Stock Is Crushing It This WeekApril 11, 2024 | theglobeandmail.comStocks See Continued Pressure as Bond Yields ClimbApril 11, 2024 | benzinga.comWhy Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?April 11, 2024 | finance.yahoo.comBiotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores OptionsApril 11, 2024 | investors.comBiotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores OptionsApril 10, 2024 | fool.comWhy Janux Therapeutics Stock Soared as the Market Sagged TodayApril 10, 2024 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Sees Unusually-High Trading VolumeJanux Therapeutics (NASDAQ:JANX) Sees Strong Trading VolumeApril 10, 2024 | msn.comJanux Therapeutics surges amid report of takeover interestApril 10, 2024 | marketbeat.comTrading was temporarily halted for "JANX" at 01:04 PM with a stated reason of "LULD pause."April 8, 2024 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Stock Price Up 6.9%Janux Therapeutics (NASDAQ:JANX) Trading 6.9% HigherApril 5, 2024 | nasdaq.comCommit To Purchase Janux Therapeutics At $25, Earn 26.5% Annualized Using OptionsApril 5, 2024 | morningstar.comJanux Therapeutics Inc Ordinary Shares JANXApril 2, 2024 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Shares Down 6.7% Janux Therapeutics (NASDAQ:JANX) Stock Price Down 6.7%March 27, 2024 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Trading Down 3.3%Janux Therapeutics (NASDAQ:JANX) Trading Down 3.3%March 21, 2024 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Given Consensus Rating of "Buy" by AnalystsJanux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) has been given an average recommendation of "Buy" by the six analysts that are covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1-year price objective among brokers thaMarch 21, 2024 | marketbeat.comBTIG Research Begins Coverage on Janux Therapeutics (NASDAQ:JANX)BTIG Research began coverage on shares of Janux Therapeutics in a research note on Thursday. They issued a "buy" rating and a $62.00 price target on the stock.March 20, 2024 | msn.comCantor starts Janux at overweight, cites TCE leadership positionMarch 20, 2024 | markets.businessinsider.comForecasting The Future: 4 Analyst Projections For Janux Therapeutics Get Janux Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. JANX Media Mentions By Week JANX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JANX News Sentiment▼0.470.56▲Average Medical News Sentiment JANX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JANX Articles This Week▼282▲JANX Articles Average Week Get Janux Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IDYA News Today XENE News Today ARWR News Today FOLD News Today HCM News Today PBH News Today RARE News Today MRUS News Today ACAD News Today MLTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JANX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Janux Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
